Literature DB >> 9804282

Immunoblot analyses of the relative contributions of cysteine and aspartic proteases to neurofilament breakdown products following experimental brain injury in rats.

R M Posmantur1, X Zhao, A Kampfl, G L Clifton, R L Hayes.   

Abstract

Analyses using either one or two-dimensional gel electrophoresis were performed to identify the contribution of several proteases to lower molecular weight (MW) neurofilament 68 (NF68) break down products (BDPs) detected in cortical homogenates following unilateral cortical impact injury in rats. One dimensional immunoblot of BDPs obtained from in vitro cleavage of enriched neurofilaments (NF) by purified micro-calpain, m-calpain, cathepsin, B, cathepsin D, and CPP32 (caspase-3) were compared to in vivo samples from rats following traumatic brain injury (TBI). Comparison of these blots provided information on the relative contribution of different cysteine or aspartic proteases to NF loss following brain injury. As early as 3 hrs post-injury, cortical impact resulted in the presence of several lower MW NF68 immunopositive bands having patterns similar to those previously reported to be produced by calpain mediated proteolysis of neurofilaments. Only micro-calpain and m-calpain in vitro digestion of enriched neurofilaments contributed to the presence of the low MW 57 kD NF68 break down product (BDP) detected in post-TBI samples. Cathepsin B, cathepsin D, and caspase-3 failed to produce either the 53 kD or 57 kD NF BDPs. Further, 1 and 2 dimensional peptide maps containing a 1:1 ratio of in vivo and in vitro tissue samples showed complete comigration of lower MW immunopositive spots produced by TBI or in vitro incubation with m-calpain, thus providing additional evidence for the potential role of calpain activation to the production of NF68 BDPs following TBI. More importantly, 2-dimensional gel electrophoresis detected that immunopositive NF68 spots shifted to the basic pole (+) suggesting that dephosphorylation of the NF68 subunit pool may be associated with NF protein loss following TBI, an observation not previously noted in any model of experimental brain injury.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9804282     DOI: 10.1023/a:1020792132629

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  82 in total

1.  Participation of cathepsins B, H, and L in perikaryal condensation of CA1 pyramidal neurons undergoing apoptosis after brief ischemia.

Authors:  T Nitatori; N Sato; E Kominami; Y Uchiyama
Journal:  Adv Exp Med Biol       Date:  1996       Impact factor: 2.622

2.  Neurofilament degradation by bovine brain cathepsin D.

Authors:  H Suzuki; M Takeda; Y Nakamura; Y Kato; K Tada; S Hariguchi; T Nishimura
Journal:  Neurosci Lett       Date:  1988-06-29       Impact factor: 3.046

3.  The proteolytic digestion of ox neurofilaments with trypsin and alpha-chymotrypsin.

Authors:  T K Chin; P A Eagles; A Maggs
Journal:  Biochem J       Date:  1983-11-01       Impact factor: 3.857

4.  Characterization of CPP32-like protease activity following apoptotic challenge in SH-SY5Y neuroblastoma cells.

Authors:  R Posmantur; K McGinnis; R Nadimpalli; R B Gilbertsen; K K Wang
Journal:  J Neurochem       Date:  1997-06       Impact factor: 5.372

5.  Changes in the activity of protein kinase C and the differential subcellular redistribution of its isozymes in the rat striatum during and following transient forebrain ischemia.

Authors:  T Wieloch; M Cardell; H Bingren; J Zivin; T Saitoh
Journal:  J Neurochem       Date:  1991-04       Impact factor: 5.372

6.  Calcium/calmodulin-dependent protein kinase II activity in focal ischemia with reperfusion in rats.

Authors:  S K Hanson; J C Grotta; M N Waxham; J Aronowski; P Ostrow
Journal:  Stroke       Date:  1994-02       Impact factor: 7.914

7.  Phosphorylation, calpain proteolysis and tubulin binding of recombinant human tau isoforms.

Authors:  J M Litersky; C W Scott; G V Johnson
Journal:  Brain Res       Date:  1993-02-26       Impact factor: 3.252

Review 8.  Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease.

Authors:  R A Nixon; K I Saito; F Grynspan; W R Griffin; S Katayama; T Honda; P S Mohan; T B Shea; M Beermann
Journal:  Ann N Y Acad Sci       Date:  1994-12-15       Impact factor: 5.691

9.  Antibodies to different isoforms of the heavy neurofilament protein (NF-H) in normal aging and Alzheimer's disease.

Authors:  L Soussan; K Tchernakov; O Bachar-Lavi; T Yuvan; E Wertman; D M Michaelson
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

10.  Ubiquitin and neurofilament expression in anterior horn cells in amyotrophic lateral sclerosis: possible clues to the pathogenesis.

Authors:  A Migheli; A Attanasio; D Schiffer
Journal:  Neuropathol Appl Neurobiol       Date:  1994-06       Impact factor: 8.090

View more
  4 in total

1.  Temporal profiles of cytoskeletal protein loss following traumatic axonal injury in mice.

Authors:  Gulyeter Serbest; Matthew F Burkhardt; Robert Siman; Ramesh Raghupathi; Kathryn E Saatman
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

Review 2.  Calpain as a therapeutic target in traumatic brain injury.

Authors:  Kathryn E Saatman; Jennifer Creed; Ramesh Raghupathi
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

3.  Biomarkers in the clinical diagnosis and management of traumatic brain injury.

Authors:  Georgene W Hergenroeder; John B Redell; Anthony N Moore; Pramod K Dash
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

4.  In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study.

Authors:  Axel Petzold; Martin M Tisdall; Armand R Girbes; Lillian Martinian; Maria Thom; Neil Kitchen; Martin Smith
Journal:  Brain       Date:  2011-02       Impact factor: 13.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.